Shanghai - Delayed Quote CNY
Guangdong Marubi Biotechnology Co., Ltd. (603983.SS)
47.40
+3.80
+(8.72%)
At close: 3:00:04 PM GMT+8
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Cash Flows from Used in Operating Activities Direct
282,865.48
300,526.86
338,022.49
48,435.68
-7,480.53
Operating Cash Flow
--
300,526.86
338,022.49
48,435.68
-7,480.53
Investing Cash Flow
320,940.67
432,191.60
-215,161.62
70,139.82
-681,135.41
Financing Cash Flow
-244,208.48
-193,149.02
-145,310.24
144,920.56
-169,843.11
Other Cash Adjustment Inside Change in Cash
--
-0
0
--
--
End Cash Position
1,371,832.25
1,579,060.01
1,039,538.95
1,061,980.37
798,515.78
Capital Expenditure
-325,608.20
-316,374.34
-254,045.49
-110,907.52
-117,137.19
Issuance of Debt
--
150,000
100,000
150,000
--
Repayment of Debt
-150,000
-248,000
-2,000
--
-106,560.30
Free Cash Flow
-42,742.72
-15,847.49
83,977.01
-62,471.84
-124,617.72
12/31/2021 - 7/25/2019
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade